These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 4392032

  • 21. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE, Izquierdo JA.
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract] [Full Text] [Related]

  • 22. Some aspects of the neuropharmacology of phenylurea.
    Zirvi KA, Fakouhi T.
    Arzneimittelforschung; 1977 Aug; 27(6):1194-8. PubMed ID: 578440
    [Abstract] [Full Text] [Related]

  • 23. [ adrenergic blocking agents and amphetamine or apomorphine induced stereotyped behavior in rats].
    Simon P, Chermat R, Fosset MT, Boissier JR.
    Psychopharmacologia; 1972 Aug; 23(4):357-64. PubMed ID: 4402045
    [No Abstract] [Full Text] [Related]

  • 24. Locomotor responses of FAST and SLOW mice to several alcohols and drugs of abuse.
    Phillips TJ, Burkhart-Kasch S, Gwiazdon CC, Crabbe JC.
    Ann N Y Acad Sci; 1992 Jun 28; 654():499-501. PubMed ID: 1632613
    [No Abstract] [Full Text] [Related]

  • 25. Salivation in mice as an index of adrenergic activity. II. The effects of atropines and ganglionic blocking agents on adrenergic salivation and temperature responses in mice.
    Koppanyi T, Maling HM.
    Arch Int Pharmacodyn Ther; 1972 Oct 28; 199(2):333-43. PubMed ID: 4403619
    [No Abstract] [Full Text] [Related]

  • 26. [Anticonvulsive properties of some derivatives of benzodiazepine].
    Vikhliaev IuI, Klygul' TA, Astakhova AV.
    Farmakol Toksikol; 1970 Oct 28; 33(2):149-54. PubMed ID: 5425619
    [No Abstract] [Full Text] [Related]

  • 27. Failure of phenoxybenzamine and pimozide to diminish changes in oxygen consumption and body temperature produced by caffeine.
    Estler CJ.
    Arch Int Pharmacodyn Ther; 1979 Jun 28; 239(2):326-30. PubMed ID: 485730
    [Abstract] [Full Text] [Related]

  • 28. Jumping activity induced by sodium 5-(1,3-dim- ethylbutyl)-5-ethyl barbiturate. II. The effects of age difference.
    Koppanyi T, Maling HM, Saul W, Brodie BB.
    Proc Soc Exp Biol Med; 1970 Mar 28; 133(3):813-6. PubMed ID: 5435574
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacological aspects of oxprenolol.
    Brunner H, Hedwall PR, Maier R, Meier M.
    Postgrad Med J; 1970 Nov 28; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R, Miragoli G, Croce G.
    Arzneimittelforschung; 1970 Aug 28; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract] [Full Text] [Related]

  • 37. Psychophysical profiles differentiate drugs of abuse.
    Hienz RD, Brady JV.
    NIDA Res Monogr; 1981 Feb 28; 34():226-31. PubMed ID: 6783937
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Antagonistic effect of beta-sympatholytics on methamphetamine-induced changes in the function and metabolism in brain].
    Estler CJ, Ammon HP.
    Arzneimittelforschung; 1970 Jul 28; 20(7):908-9. PubMed ID: 5536056
    [No Abstract] [Full Text] [Related]

  • 40. Toxicological and pharmacological effects of D-arginine.
    Navarro E, Alonso SJ, Martín FA, Castellano MA.
    Basic Clin Pharmacol Toxicol; 2005 Sep 28; 97(3):149-54. PubMed ID: 16128908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.